The Motley Fool Discussion Boards
Stocks H / Halozyme Therapeutics
|Subject: Re: When will this run-up end?||Date: 4/29/2007 7:59 AM|
|Author: stillwater9999||Number: 22 of 31|
The most recent drivers here have been:
1) The purchase of shares in a private sale by former New River management - this is RJ Kirk buying more basically. He already owns 10%+. There is serious speculation that he may try to acquire the whole company. He easily has the money after his recent sale of New River Pharmaceuticals to Shire for over 2 billion dollars. Kirk really seems to think the technology here will be huge. He likes these plays that can extend patent life for major drugs (this continues to be one of the biggest themes in all of Pharma).
2) The launch by Baxter of Hylenex in Opthalmic surgery - probably not a big deal financially but this stock is very news driven.
I have actually trimmed my position. I am up almost 4x from the initial purchase price on what I have left. Overall at this price it seems somewhat speculative to me. Could be a pullback if no new major deals materialize, but there is a real chance Kirk may buy the whole thing as his new vehicle post NRPH.
sw - owner of HTI in an individual account
|Copyright 1996-2017 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us|